CIBCX
Price
$79.98
Change
+$0.42 (+0.53%)
Updated
Oct 20 closing price
Net Assets
119.59B
RALOX
Price
$10.91
Change
+$0.06 (+0.55%)
Updated
Oct 20 closing price
Net Assets
5.75M
Interact to see
Advertisement

CIBCX vs RALOX

Header iconCIBCX vs RALOX Comparison
Open Charts CIBCX vs RALOXBanner chart's image
American Funds Capital Income Bldr C
Price$79.98
Change+$0.42 (+0.53%)
VolumeN/A
Net Assets119.59B
Lazard Real Assets Open
Price$10.91
Change+$0.06 (+0.55%)
VolumeN/A
Net Assets5.75M
CIBCX vs RALOX Comparison Chart in %
View a ticker or compare two or three
VS
CIBCX vs. RALOX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIBCX is a Buy and RALOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIBCX has more cash in the bank: 120B vs. RALOX (5.75M). RALOX pays higher dividends than CIBCX: RALOX (4.98) vs CIBCX (2.20). CIBCX was incepted earlier than RALOX: CIBCX (25 years) vs RALOX (9 years). RALOX (3.85) is less costly to investors than CIBCX (1.34). CIBCX is a more actively managed with annual turnover of: 56.00 vs. RALOX (31.00). CIBCX has a lower initial minimum investment than RALOX: CIBCX (250) vs RALOX (2500). CIBCX annual gain was more profitable for investors over the last year : 9.97 vs. RALOX (8.22). CIBCX return over 5 years is better than : 48.06 vs. RALOX (42.64).
CIBCXRALOXCIBCX / RALOX
Total Expense Ratio1.341.09123%
Annual Report Gross Expense Ratio1.343.8535%
Fund Existence25 years9 years-
Gain YTD16.40113.847118%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets120B5.75M2,088,773%
Annual Yield % from dividends2.204.9844%
Returns for 1 year9.978.22121%
Returns for 3 years44.6028.47157%
Returns for 5 years48.0642.64113%
Returns for 10 years55.15N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QVCGP5.490.34
+6.60%
QVC Group Inc.
MUSA387.287.71
+2.03%
Murphy USA
XERS9.240.10
+1.09%
Xeris Biopharma Holdings
SPOK15.860.14
+0.89%
Spok Holdings
WCT0.32-0.01
-3.54%
Wellchange Holdings Co Ltd